Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Eur J Pharmacol ; 831: 77-86, 2018 Jul 15.
Article in English | MEDLINE | ID: mdl-29738701

ABSTRACT

Increasing evidence suggests that flavones can modulate memory and anxiety-like behaviour. However, these therapeutic effects are inconsistent and induce of adverse effects, which have been associated with interactions at the Benzodiazepine (BZ)-binding site. To improve our understanding of flavone effects on memory and anxiety, we employed a plus-maze discriminative avoidance task. Furthermore, we evaluated the potential of the compounds in modulating GABAA receptors via BZ-binding site using molecular modelling studies. Adult male Wistar rats were treated 30 min before training session with Vicenin-2 (0.1 and 0.25 mg/kg), Vitexin (0.1 and 0.25 mg/kg), Isovitexin (0.1 and 0.25 mg/kg) and 0.1 mg/kg 6-C-glycoside-Diosmetin, vehicle and a GABAA receptor agonist. The analysis of the time spent in the non-aversive vs aversive enclosed arms during the test session and percentage of time in the open arms within the training session revealed that treatment with Isovitexin and 6-C-glycoside-Diosmetin had memory-enhancing and anxiolytic-like effects (P < 0.001). In contrast, treatment with a higher dose of Diazepam impaired short-and long-term memory when it alleviated anxiety level. Docking studies revealed that flavones docked in a very similar way to that observed to the Diazepam, except by a lack of interaction in residue α1His101 in the BZ-binding site on GABAA receptors, which may be related to memory-enhancing effect. The occurrence of the α1His101 interaction could justify the memory-impairing observed following Diazepam treatment. These findings provide the first evidence that Isovitexin and 6-C-glycoside-Diosmetin could exert their memory-enhancing and anxiolytic-like effects via GABAA receptor modulation, which likely occurs via their benzodiazepine-binding site.


Subject(s)
Anti-Anxiety Agents/pharmacology , Apigenin/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Cognition/drug effects , Diazepam/pharmacology , Flavonoids/pharmacology , Nootropic Agents/pharmacology , Receptors, GABA-A/drug effects , Animals , Anti-Anxiety Agents/chemistry , Anti-Anxiety Agents/metabolism , Apigenin/chemistry , Apigenin/metabolism , Avoidance Learning/drug effects , Binding Sites , Brain/metabolism , Diazepam/chemistry , Diazepam/metabolism , Discrimination Learning/drug effects , Dose-Response Relationship, Drug , Flavonoids/chemistry , Flavonoids/metabolism , Locomotion , Male , Maze Learning/drug effects , Memory, Long-Term/drug effects , Memory, Short-Term/drug effects , Molecular Docking Simulation , Nootropic Agents/chemistry , Nootropic Agents/metabolism , Protein Binding , Protein Conformation , Rats, Wistar , Receptors, GABA-A/chemistry , Receptors, GABA-A/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL